×
返回 Agenda
Session Chair(s)
Nata Menabde
Representative to India
WHO, India
Speaker(s)
Preclinical Data Integrity and Scientific Quality from a Regulatory Reviewer’s Perspective
Qingli WANG
Division of Pharmacological and Toxicological Review, CDE, CFDA , China
Deputy Director, Senior Reviewer on Clinical Trials
FDA's Expectation on Nonclinical Data Integrity with Special Emphases on Data Generated by CROs - Case Study
Dylan YAO, MD, PHD
Joinn Laboratories, Inc., China
Senior Vice President and CSO
Honggang Bi, PHD
Covance, China
Corporate Vice President, General Manager China
Robert Coldreck
WuXi AppTec (Suzhou) Co., Ltd., China
Vice President, GLP QA